Engrail Therapeutics raised $32M Series A Plus venture round, led by Peter Bisgaard.
This funding round does not have an about section yet.
| Investor | Firm Type | Partner |
|---|
| Venture Capital | — |
This company has completed 3 funding rounds. Current round is highlighted.
Total Raised
$224M
Top Valuation
-
Engrail Therapeutics raised $32M in a Series A Plus round.
The round was announced on 08/03/21.
The round was led by Peter Bisgaard.